Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA Expression as Biomarker of Omalizumab Response in Asthma
NCT01584687Phase 4Unknown
- Sponsor
- Instituto de Investigação em Imunologia
- Start
- Jun 2012
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of omalizumab in asthma, sponsored by Instituto de Investigação em Imunologia. Status: unknown.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01584687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584687.